CTNNB1 and adrenal cortex carcinoma: Although this knowledge originates mostly from mouse genetic studies, the high prevalence of CTNNB1 and ZNRF3 driver mutations in human adrenocortical carcinoma (ACC) shows the relevance of these pathways for human adrenal disease (Assié et al., 2014; Zheng et al., 2016).